In Geron's Wake
Deals, Data Spark Stem Cell Interest, But Hurdles Remain
By Trista Morrison
Monday, December 12, 2011
SAN DIEGO – Geron Inc.'s exit from the embryonic stem cell field last month shocked many in the biotech industry – but not the regenerative medicine experts attending the recent 2011 Stem Cell Meeting on the Mesa.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.